Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M Cruijsen*, W J F M van der Velden, A F J de Haan, S K Klein, M Hoogendoorn, Y Tromp, B de Valk, B van Rees, F de Boer, E van der Spek, J Pruijt, L F Verdonck, E Vellenga, N Blijlevens, A A van de Loosdrecht, G Huls

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)2752-2755
Number of pages4
JournalLeukemia & Lymphoma
Volume61
Issue number11
Early online date1-Jun-2020
DOIs
Publication statusPublished - Nov-2020

Keywords

  • RISK MYELODYSPLASTIC SYNDROMES
  • CANCER
  • MDS

Cite this